Skip to main navigation Skip to search Skip to main content

Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)

  • Matthew Ingham
  • , Jacob B. Allred
  • , Li Chen
  • , Biswasjit Das
  • , Bose Kochupurakkal
  • , Katherine Gano
  • , Suzanne George
  • , Steven Attia
  • , Melissa A. Burgess
  • , Mahesh Seetharam
  • , Sosipatros A. Boikos
  • , Nam Bui
  • , James L. Chen
  • , Julia L. Close
  • , Gregory M. Cote
  • , Premal H. Thaker
  • , S. Percy Ivy
  • , Sminu Bose
  • , Alan D'Andrea
  • , Adrian Marino-Enriquez
    • Geoffrey I. Shapiro, Gary K. Schwartz

Research output: Contribution to journal › Article › peer-review

39   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science